City

Chicago (1)

New York (1)

Saint Louis (1)

Condition

Myelofibroses (3)

Acute Myeloid Leukemia (1)

Chronic Myeloid Leukemia (1)

Myelodysplastic Syndromes (1)

Overall Status

Terminated (2)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

Sponsor

NYU Langone Health (1)

University of Chicago (1)

Washington University School of Medicine (1)

Collaborator

Takeda (1)

Intervention

azacitidine (1)

azd1775 only (1)

combination azd1775 with arac (1)

peripheral blood draw (1)

pevonedistat (1)

ruxolitinib (1)

selumetinib (1)

skin biopsy (1)

Study Documents

Intervention Type

drug (3)

procedure (1)

Funder Type

Other (3)

Study Type

Interventional (3)

myelofibroses

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Chronic Myeloid Leukemia, Myelofibroses Trial in Chicago (Azacitidine, Selumetinib)

Recruiting

Chronic Myeloid Leukemia
Myelofibroses

Chicago, Illinois

The University of Chicago

May 16, 2022

Myelofibroses Trial in Saint Louis (Pevonedistat, Ruxolitinib, Peripheral blood draw)

Terminated

Myelofibroses

Pevonedistat
+3 more

Saint Louis, Missouri

Washington University School of Medicine

Dec 16, 2021

Myelofibroses, Acute Myeloid Leukemia, MDS Trial in New York (Combination AZD1775 with AraC, AZD1775 only)

Terminated

Has Results

Myelofibroses
+2 more

Combination AZD1775 with AraC
AZD1775 only

New York, New York

NYU Langone Health

May 20, 2020